Search Results - Bayer Company Press Release
- Showing 1 - 2 results of 2
-
1
Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA by Bayer Company Press Release
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA by Bayer Company Press Release
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book